
PeptiDream Announces Nomination of Second Peptide Radiopharmaceutical Therapeutic Development Candidate
KANAGAWA, Japan–(BUSINESS WIRE)–#Glypican3–PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President and CEO: Patrick C. Reid, hereinafter “PeptiDream”) (Tokyo: 4587) today announced the nomination of […]












